Related Experiment Video
Updated: Feb 12, 2026
05:17
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
428
Whole-genome sequencing and cancer therapy: is too much ever enough?
Levi A Garraway1, José Baselga
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. levi_garraway@dfci.harvard.edu
Cancer Discovery
|September 13, 2012
Abstract:
This issue of Cancer Discovery features an article that describes the use of whole-genome sequencing to discover an actionable genetic alteration that was not detected using a lower resolution diagnostic approach. This finding highlights the growing debate surrounding the optimal deployment of powerful new genomics technologies in the clinical oncology arena.
